Medios Value Stock - Dividend - Research Selection
Market price: 28,70 EUR
Medios AG Fundamental data and company key figures of the share
|Annual reports in EUR|
|Net operating cash flow||-449.286|
|Free cash flow||-2.538.606|
|Liabilities & Shareholders equity||116.567.000|
|Diluted shares outstanding||15.015.200|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||503.900.512,00 USD|
|Raw Data Source||IFRS in Millionen EUR|
Description of the company
Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. The company offers infusions for patients with rare or chronic diseases, such as cancer, HIV, and hepatitis. It also manufactures drugs for patients on behalf of pharmacies. The company was founded in 2016 and is headquartered in Berlin, Germany. Medios AG is a subsidiary of mediosmanagement GmbH.